Dr. Leo Nissola stands at the forefront of a scientific revolution, a medical doctor and clinical developer whose groundbreaking research has shaped how governments, industries, and individuals approach human health and its boundless potential. Renowned for his bestselling book The Immunity Solution (W.W. Norton & Company, 2025), his pioneering work since the early days of the COVID-19 pandemic, and early-phase immunotherapy clinical trials, Dr. Nissola has cemented his status as both a visionary scientist and a pragmatic strategist.
In The Immunity Solution, Dr. Nissola leverages decades of expertise to unveil the insidious threats posed by seed oils, synthetic food additives, and environmental microplastics, while advocating for a bold, coordinated public-health response. The book’s impact was immediate and global—eclipsing Prince Harry’s memoir on Amazon upon release and dominating bestseller lists across the United States, United Kingdom, Commonwealth nations, China, and Brazil.
This month, Dr. Nissola’s warnings resonated at the highest levels of power. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has embraced many of his recommendations, urging Congress to ban seed oils and food dyes, phase out microplastics, and elevate preventative health as a national priority. “Secretary Kennedy is asking what these substances are doing to our children—and he’s absolutely right,” Dr. Nissola asserts.
“More than preventative health, we need new biotechnologies. My firm, FIRSTBIO Research, holds exclusive data showing how some new technologies can transform global health. I’m thrilled to see unprecedented support from HHS for advancing psychedelic therapies and accelerating FDA clinical trials. Patients can’t wait for bureaucracy to catch up.”
Dr. Nissola’s influence is undeniable—and it’s about to deepen. When asked whether a new book is on the horizon, he smiles knowingly. “Writing is my passion,” he says. “I’ve been developing an exclusive dataset for years, and I’m finally ready to share what I’ve uncovered.”
Though he offers few details, he hints that the forthcoming work will challenge conventional wisdom and may stir debate. “It won’t be for everyone,” he adds, “but the truth rarely is.”
“I’m drawn to unconventional thinkers—those unafraid to say what others won’t,” Dr. Nissola reflects. “If it weren’t for Christian Angermayer’s vision and persistence, the psychedelic medicine field might have collapsed years ago. Instead, we’re now witnessing the blossoming of the seeds he dared to plant when few would even speak their names.”
He pauses, then adds with measured conviction: “It’s the first time in history that HHS has embraced psychedelic therapies and fast-tracked clinical trials. This administration is delivering a profound service to humanity.”
The Italian-Brazilian doctor’s voice reverberates beyond the lab and boardroom. Invited to NATO’s 2025 biotechnology and human enhancement conference, speaking at the U.K. Parliament’s Palace of Westminster, and advising the revolutionary Enhanced Games movement—supported by luminaries like Peter Thiel, Balaji Srinivasan, and Christian Angermayer—Dr. Nissola is a global thought leader. His insights grace BBC, CBS, Fox, MSNBC, and NBC, while his essays enrich The Hill, NBC News, San Francisco Chronicle, and USA Today.
Behind this policy triumph lies a career of remarkable achievements. An award-winning immunologist and cancer researcher, Dr. Nissola was a linchpin during the COVID-19 pandemic, crafting data-driven epidemiological models that shaped White House briefings and national strategies. Simultaneously, he spearheaded early-phase immunotherapy trials at the Parker Institute for Cancer Immunotherapy, enrolling patients at top-tier academic centers nationwide.
His industry credentials are equally formidable. Dr. Nissola has managed multi-billion-dollar drug portfolios at leading biopharmaceutical firms, served as a medical oncology research fellow at MD Anderson Cancer Center, and earned the rare distinction of “Individual of Extraordinary Ability” under U.S. immigration law.
Through FIRSTBIO Research—the medical-intelligence advisory firm he founded—Dr. Nissola counsels a diverse clientele, from government policymakers to venture capitalists, on early-phase clinical development and transformative technologies. “Real-world data is gold,” he asserts, yet in an age awash with both insight and misinformation, trust remains indispensable.
When pressed on his own intellectual anchors, Dr. Nissola names a deliberate fusion of classical thought and contemporary visionaries.
“Every morning, I begin with meditation and try to implement the rigorous inquiry of Plato, Schopenhauer, Kant, and Nietzsche in my decisions,” he explains. “Their insights into ethics, being, and the limits of human understanding ground my work.” But he insists those foundations must yield to the demands of our era. “The playbooks of the past are obsolete in an age defined by AI, robotics, and human enhancement. We must forge new technologies swiftly and with vision.”
To that end, he turns to a circle of modern architects of innovation and policy. “Peter Thiel’s vision of the future inspires me. Balaji Srinivasan’s The Network State reshaped my understanding of the world. And on the front lines of human performance, Dr. Aròn De Souza’s leadership at the Enhanced Games shows me what’s possible when scientific rigor meets athletic ambition. I listen to what they have to say, and they are often correct.”
By blending timeless philosophy with the strategic insights of today’s leading thinkers, Dr. Nissola ensures that FIRSTBIO Research remains at the nexus of credibility, creativity, and real-world impact.
His ultimate ambition is as audacious as it is profound: digital immortality via consciousness uploading. This dream weaves together his mastery of immunology, policy influence, and unshakable faith in science’s capacity to transcend human boundaries.
As governments and institutions mobilize around his recommendations, one truth becomes clear: wherever tomorrow’s scientific frontiers lie, Dr. Leo Nissola will be there. Probably first.
Learn more: FIRSTBIO Research at FIRSTBIO.ORG
Find The Immunity Solution: Available in the U.S., U.K., Commonwealth, Brazil, and China, and on Amazon and Audible worldwide.
